HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George V Papatheodoridis Selected Research

Aftercare (After-Treatment)

1/2022Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study.
1/2020Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B.
4/2016The significance of platelet microparticles in patients with chronic hepatitis C and their association with antiviral treatment and smoking.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George V Papatheodoridis Research Topics

Disease

55Chronic Hepatitis B
11/2022 - 07/2002
38Fibrosis (Cirrhosis)
01/2022 - 02/2003
19Liver Diseases (Liver Disease)
10/2022 - 07/2002
18Infections
01/2022 - 07/2002
17Hepatitis B
11/2022 - 03/2003
17Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2010
14Non-alcoholic Fatty Liver Disease
10/2022 - 11/2006
14Chronic Hepatitis C
05/2020 - 04/2006
6Hepatitis
01/2019 - 04/2005
5Neoplasms (Cancer)
01/2022 - 04/2007
5Hepatitis D
01/2022 - 01/2014
4Viremia
11/2008 - 07/2002
3Coinfection
01/2021 - 11/2014
3Weight Loss (Weight Reduction)
01/2018 - 02/2011
3Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2013 - 11/2006
2Hepatitis E
01/2022 - 07/2005
2Inflammation (Inflammations)
11/2021 - 11/2006
2Hematologic Diseases (Blood Diseases)
07/2018 - 01/2017
2Overweight
01/2018 - 10/2016
2Insulin Resistance
03/2017 - 12/2007
2Hepatitis C
02/2017 - 01/2017
2Chronic Renal Insufficiency
02/2017 - 11/2013
2Alcoholic Fatty Liver
01/2017 - 01/2008
2Fatty Liver
01/2017 - 04/2010
2Alcoholism (Alcohol Abuse)
11/2014 - 04/2007
2Virus Diseases (Viral Diseases)
12/2013 - 03/2008
2Sclerosing Cholangitis
02/2008 - 04/2007
2Peptic Ulcer (Peptic Ulcers)
02/2006 - 05/2004
2Hemorrhage
02/2006 - 05/2004
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
12/2003 - 08/2002
1Chronic Disease (Chronic Diseases)
10/2022
1Fatigue
10/2022
1End Stage Liver Disease
09/2021
1Communicable Diseases (Infectious Diseases)
01/2021
1Carcinoma (Carcinomatosis)
01/2021
1Chronic Hepatitis (Chronic Active Hepatitis)
01/2020
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
01/2019

Drug/Important Bio-Agent (IBA)

38Hepatitis B e AntigensIBA
11/2022 - 07/2002
32Antiviral Agents (Antivirals)IBA
11/2022 - 07/2002
19Hepatitis B Surface Antigens (HBsAg)FDA Link
01/2021 - 10/2003
18Tenofovir (Viread)FDA Link
01/2022 - 12/2008
18entecavirFDA Link
01/2022 - 03/2008
15Lamivudine (Epivir)FDA Link
01/2017 - 07/2002
12DNA (Deoxyribonucleic Acid)IBA
01/2022 - 10/2003
11InterferonsIBA
01/2021 - 07/2005
9Interferon-alpha (Interferon Alfa)IBA
01/2021 - 03/2008
8RNA (Ribonucleic Acid)IBA
11/2022 - 08/2010
7AntigensIBA
11/2022 - 10/2003
7nasIBA
01/2021 - 02/2013
7Alanine Transaminase (SGPT)IBA
01/2018 - 04/2007
5EnzymesIBA
01/2022 - 05/2004
5Pharmaceutical PreparationsIBA
01/2017 - 08/2004
5adefovirIBA
11/2011 - 01/2003
4AdipokinesIBA
01/2009 - 11/2006
3Immunoglobulins (Immunoglobulin)IBA
01/2021 - 03/2003
3peginterferon alfa-2a (Pegasys)FDA Link
01/2019 - 11/2018
3Transaminases (Aminotransferases)IBA
01/2019 - 12/2008
3gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2018 - 04/2007
3AdiponectinIBA
03/2017 - 11/2006
3Ribavirin (Virazole)FDA LinkGeneric
04/2016 - 08/2010
3Proteins (Proteins, Gene)FDA Link
01/2016 - 02/2008
3Immunoglobulin M (IgM)IBA
01/2014 - 10/2003
3Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2013 - 04/2006
3adefovir dipivoxil (Hepsera)FDA Link
01/2011 - 08/2004
3NucleosidesIBA
08/2006 - 07/2002
2Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2014
2hepatitis B hyperimmune globulinIBA
01/2021 - 03/2003
2Rituximab (Mabthera)FDA Link
07/2018 - 01/2017
2Glucose (Dextrose)FDA LinkGeneric
03/2017 - 01/2012
2Triglycerides (Triacylglycerol)IBA
03/2017 - 01/2012
2SofosbuvirIBA
02/2017 - 01/2014
2NucleotidesIBA
12/2013 - 08/2006
2CreatinineIBA
11/2011 - 05/2005
2Keratin-18 (Keratin 18)IBA
01/2011 - 04/2010
2TelbivudineFDA Link
12/2008 - 03/2008
2LeptinIBA
01/2008 - 11/2006
2Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
02/2006 - 05/2004
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
12/2003 - 08/2002
1ethyl 4-chloro-3-hydroxybutanoate (CHBE)IBA
01/2022
1tenofovir alafenamideIBA
01/2022
1Diphosphonates (Bisphosphonates)IBA
01/2022
1Cell-Free Nucleic AcidsIBA
11/2021
1QuercetinIBA
11/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2021
1Dietary Fats (Dietary Fat)IBA
11/2021
1FlavonoidsIBA
11/2021
1Galectin 3 (LGALS3)IBA
09/2021
1SodiumIBA
09/2021
1Cytidine Triphosphate (CTP)IBA
09/2021
1AlbuminsIBA
06/2021
1AutoantibodiesIBA
01/2019
1Azathioprine (Imuran)FDA LinkGeneric
01/2019

Therapy/Procedure

52Therapeutics
11/2022 - 07/2002
11Liver Transplantation
01/2022 - 03/2003
3Aftercare (After-Treatment)
01/2022 - 04/2016
3Retreatment
01/2020 - 01/2018
3Contraindications
02/2017 - 11/2010
3Transplantation
07/2005 - 03/2003
2Kidney Transplantation
02/2017 - 11/2013
1Precision Medicine
12/2020